NOVAVAX INC Business Operations Contracts & Agreements

37 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Termination and Settlement Agreement between Novavax, Inc. and UK Health Security Agency (November 2024)
Settlement Agreements
NOVAVAX INC
Biotechnology
2025
Termination and Settlement Agreement between Novavax, Inc. and UK Secretary of State for Health and Social Care (UKHSA)
Settlement Agreements
NOVAVAX INC
Biotechnology
DE
2025
Confidential Settlement Agreement and Release between Novavax, Inc. and FUJIFILM Diosynth Biotechnologies Entities (March 21, 2024)
Settlement Agreements
NOVAVAX INC
Biotechnology
TX
2024
Termination and Settlement Agreement between Gavi Alliance and Novavax, Inc. (February 16, 2024)
Termination Agreements
NOVAVAX INC
Biotechnology
2024
Settlement Agreement and General Release between Novavax, Inc. and SK bioscience Co., Ltd. (August 8, 2023)
Settlement Agreements
NOVAVAX INC
Biotechnology
2023
Confidential Settlement Agreement and Release between Novavax, Inc. and FUJIFILM Diosynth Biotechnologies Entities (September 30, 2022)
Settlement Agreements
NOVAVAX INC
Biotechnology
2022
Amended and Restated SARS-CoV-2 Vaccine Supply Agreement between Novavax, Inc. and the UK Secretary of State for Business, Energy and Industrial Strategy (as of July 1, 2022)
Supply Agreements
NOVAVAX INC
Biotechnology
WA
2022
Statement of Work No. 1 to Contract Development Manufacture Agreement between Serum Life Sciences Limited and Novavax, Inc.
Supply Agreements
NOVAVAX INC
Biotechnology
2022
Contract Development and Manufacture Agreement between Serum Life Sciences Limited and Novavax, Inc. dated October 21, 2021
Development Agreements
NOVAVAX INC
Biotechnology
2022
Change Order No. 1 to Statement of Work under Collaboration and License Agreement between Novavax, Inc. and SK bioscience Co., Ltd.
Collaboration Agreements
NOVAVAX INC
Biotechnology
2022
Statement of Work No. 1 between Novavax, Inc. and SK bioscience Co., Ltd. for Antigen Product Manufacturing Services
Services Agreements
NOVAVAX INC
Biotechnology
2022
First Amendment to Collaboration and License Agreement between Novavax, Inc. and SK bioscience Co., Ltd.
Collaboration Agreements
NOVAVAX INC
Biotechnology
2022
Supply Agreement between Novavax, Inc., Serum Institute of India Pvt. Ltd., and Serum Life Sciences Limited
Supply Agreements
NOVAVAX INC
Biotechnology
2022
Amended and Restated Supply and License Agreement between Serum Institute of India Private Limited and Novavax, Inc.
Supply Agreements
NOVAVAX INC
Biotechnology
2021
Collaboration and License Agreement between Novavax, Inc. and SK bioscience Co., Ltd. (February 12, 2021)
Collaboration Agreements
NOVAVAX INC
Biotechnology
2021
SARS-CoV-2 Vaccine Supply Agreement, effective as of October 22, 2020, between Novavax, Inc. and The Secretary of State for Business, Energy and Industrial Strategy, acting on...
Supply Agreements
NOVAVAX INC
Biotechnology
2021
U.S. Army Contracting Command and Novavax, Inc. Letter Contract for COVID-19 Vaccine Development and Production
Development Agreements
NOVAVAX INC
Biotechnology
2020
Amendment No. 4 to Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc.
Services Agreements
NOVAVAX INC
Biotechnology
2014
Amendment No. 3 to Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc.
Services Agreements
NOVAVAX INC
Biotechnology
2013
Amendment No. 2 to Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc.
Services Agreements
NOVAVAX INC
Biotechnology
2013
Amendment No. 1 to Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc.
Services Agreements
NOVAVAX INC
Biotechnology
2011
Novavax Guidelines on Significant Corporate Governance Issues Effective January 1, 2011
Code of Ethics
NOVAVAX INC
Biotechnology
2011
Advanced Development and Manufacturing Agreement for Recombinant Influenza Vaccines between [Company] and HHS/OS/ASPR/BARDA (Effective February 24, 2011)
Development Agreements
NOVAVAX INC
Biotechnology
2011
Materials Transfer Agreement between Novavax, Inc. and Laboratorio Avi-Mex S.A. de C.V. dated October 19, 2009
Collaboration Agreements
NOVAVAX INC
Biotechnology
MD
2009
Amended and Restated Technical Services Agreement between Novavax, Inc. and CPL Biologicals Private Limited (June 29, 2009)
Services Agreements
NOVAVAX INC
Biotechnology
2009
Amended and Restated Supply Agreement between Novavax, Inc. and CPL Biologicals Private Limited (June 29, 2009)
Supply Agreements
NOVAVAX INC
Biotechnology
2009
Amended and Restated Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc.
Services Agreements
NOVAVAX INC
Biotechnology
2009
Technical Services Agreement between Novavax, Inc. and CPL Biologicals Limited (March 31, 2009)
Services Agreements
NOVAVAX INC
Biotechnology
2009
Supply Agreement between Novavax, Inc. and CPL Biologicals Limited dated March 31, 2009
Supply Agreements
NOVAVAX INC
Biotechnology
2009
Master Services Agreement between Cadila Pharmaceuticals Limited and Novavax, Inc. (March 31, 2009)
Services Agreements
NOVAVAX INC
Biotechnology
2009
Termination of Sublease Agreement between Human Genome Sciences, Inc. and Novavax, Inc.
Termination Agreements
NOVAVAX INC
Biotechnology
DE
2008
Supply and Lease Letter Agreement between Novavax, Inc. and Catalent Pharma Solutions, Inc. (February 12, 2008)
Supply Agreements
NOVAVAX INC
Biotechnology
2008
Supply Agreement between Novavax, Inc. and Graceway Pharmaceuticals, LLC dated February 19, 2008
Supply Agreements
NOVAVAX INC
Biotechnology
2008
Supply Agreement between Novavax, Inc. and Esprit Pharma, Inc. (April 21, 2006)
Supply Agreements
NOVAVAX INC
Biotechnology
2006
Supply Agreement between Novavax, Inc. and Esprit Pharma, Inc. dated October 18, 2005
Supply Agreements
NOVAVAX INC
Biotechnology
2006
Second Amendment to Copromotion Agreement between King Pharmaceuticals, Inc. and Novavax, Inc.
Collaboration Agreements
NOVAVAX INC
Biotechnology
2001
Copromotion Agreement between Novavax, Inc. and King Pharmaceuticals, Inc. dated January 8, 2001
Collaboration Agreements
NOVAVAX INC
Biotechnology
DE
2001